According to a recent assessment by the World Health Organization (WHO), next-generation influenza vaccines that offer broader and longer-lasting protection than current seasonal formulations could significantly reduce the worldwide impact of influenza. The new WHO Full Value of Improved Influenza Vaccine Assessment (FVIVA), published alongside an article in the journal Vaccine, examines the public health, economic, and policy implications of next-generation influenza vaccines. It also outlines